プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
treatment of fabry disease
treatment of fabry disease
最終更新: 2011-10-23
使用頻度: 1
品質:
警告: このアラインメントは正しくない可能性があります。
間違っていると思う場合は削除してください。
fabry sygdom er en nedarvet heterogen og multisystemisk progressiv sygdom, der rammer både mænd og kvinder.
fabry disease is an inherited heterogeneous and multisystemic progressive disease, that affects both males and females.
hos mandlige pædiatriske fabry- patienter kan hyperfiltrering være den tidligste manifestation af, at nyrerne er involveret i sygdommen.
in male paediatric fabry patients, hyperfiltration can be the earliest manifestation of renal involvement in the disease.
fabrazyme anvendes som ensymerstatningsbehandling ved fabry sygdom, hvor α- galaktosidase enzymaktiviteten enten helt mangler eller er lavere end normalt.
fabrazyme is used as enzyme replacement therapy in fabry disease, where the level of α - galactosidase enzyme activity is absent or lower than normal.
udvalget for humanmedicinske lægemidler (chmp) besluttede, at for patienter med fabry sygdom kan fabrazyme give kliniske fordele på lang sigt.
the committee for medicinal products for human use (chmp) decided that, for patients with fabry disease, treatment with fabrazyme might provide long-term clinical benefits.
personer med fabrys sygdom kan have en lang række tegn og symptomer, herunder alvorlige lidelser såsom nyresvigt, hjerteproblemer og slagtilfælde.
people with fabry disease may have a wide range of signs and symptoms, including severe conditions such as kidney failure, heart problems and stroke.